Bayer Shells Out More Over Baycol

Law360, New York (January 23, 2007, 12:00 AM EST) -- Bayer Corp. has agreed to pay $8 million to 30 states to settle allegations that the drug company failed to adequately warn consumers about the safety risks associated with recalled cholesterol-lowering drug Baycol.

In disclosing the settlement Tuesday, Pennsylvania Attorney General Tom Corbett said that Bayer learned that risks associated with the drug were significantly greater than those with other similar drugs following the May 1998 introduction of Baycol to the U.S. market. That was especially true when Baycol was used in higher doses or in...
To view the full article, register now.